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Foxp3+ regulatory T (Treg) cells limit inflammatory
responses and maintain immune homeostasis.
Although comprised of several phenotypically and
functionally distinct subsets, the differentiation of
specialized Treg cell populations within the periph-
ery is poorly characterized. We demonstrate that
the development of T-bet+ Treg cells that potently
inhibit T helper 1 (Th1) cell responses was dependent
on the transcription factor STAT1 and occurred
directly in response to interferon-g produced by
effector T cells. Additionally, delayed induction of
the IL-12Rb2 receptor component after STAT1 acti-
vation helped ensure that Treg cells do not readily
complete STAT4-dependent Th1 cell development
and lose their ability to suppress effector T cell prolif-
eration. Thus, we define a pathway of abortive Th1
cell development that results in the specialization of
peripheral Treg cells and demonstrate that impaired
expression of a single cytokine receptor helps main-
tain Treg cell-suppressive function in the context of
inflammatory Th1 cell responses.
INTRODUCTION
The appropriate differentiation of naive T helper cells into func-
tionally specialized effector lineages is critical for generating
productive immune responses against different types of patho-
gens. T helper 1 (Th1) cells are required for immunity to intra-
cellular pathogens and develop from naive precursors via a
multistep mechanism involving sequential activation of the tran-
scription factors STAT1, T-bet, and STAT4. Initially, T cell
receptor (TCR) stimulation in conjunction with STAT1 activation
by cytokines such as IFN-g induce low-level expression of the
transcription factor T-bet, which in turn drives expression of
the inducible IL-12 receptor component IL-12Rb2 (Afkarian
et al., 2002; Mullen et al., 2001). This allows the cells to undergo
IL-12-dependent activation of STAT4, whereupon STAT4 and
T-bet act independently and synergistically to drive expression
of the signature inflammatory cytokine IFN-g, as well as otherImgenes required for the proper function of Th1 cells (Thieu et al.,
2008; Wei et al., 2010).
In addition to effector Th subsets, Foxp3+ regulatory T (Treg)
cells comprise a distinct CD4+ T cell lineage important for damp-
ening inflammation and preventing autoimmunity (Sakaguchi
et al., 2008). Treg cell differentiation occurs primarily in the
thymus, where developing T cells upregulate Foxp3 upon recog-
nition of self-antigen and stimulation with IL-2 or IL-15. Thus, the
TCR repertoire of Treg cells is believed to be heavily biased
toward autoreactivity (Lio and Hsieh, 2011). Like conventional
CD4+ Th cells, Treg cells can be subdivided into distinct subsets
on the basis of differential expression of homing receptors and
activation markers (Huehn et al., 2004; Min et al., 2007), and
multiple functional mechanisms of suppression have been
ascribed to Treg cells (Vignali et al., 2008; Shevach, 2009;
Tang and Bluestone, 2008). Indeed, the ability of Treg cells to
control different types of Th cell responses depends on their
expression of specific Th cell-associated transcription factors
(Chaudhry et al., 2009; Koch et al., 2009; Zheng et al., 2009).
For example, although T-bet is considered the ‘‘master regu-
lator’’ of Th1 cell differentiation, Treg cells selectively upregulate
T-bet during type 1 inflammatory responses in vivo, and T-bet-
deficient Treg cells display diminished expression of the Th1
cell-associated chemokine receptor CXCR3 and fail to rescue
Foxp3-deficient mice from Th1 cell-mediated inflammatory
disease (Koch et al., 2009). Thus, the phenotypic and functional
heterogeneity of Treg cells helps ensure that they can modulate
different types of immune responses in both lymphoid and non-
lymphoid tissue sites (Campbell and Koch, 2011).
The diversity of peripheral Treg cells suggests that they
alter their migratory, functional, and homeostatic properties in
response to contextual cues from the immune environment.
However, the mechanisms guiding the development of special-
ized Treg cell subsets, and the ways in which they mirror and
diverge from the comparatively well-characterized pathways
of effector T cell differentiation, have not been extensively
explored. In addition, the autoreactivity of Treg cells presents
a significant danger if they were to acquire proinflammatory
effector functions. Thus, strict mechanisms that limit the func-
tional reprogramming of Treg cells during strong inflammatory
responses are thought to exist. For instance, despite upregulat-
ing T-bet during Th1 cell inflammatory responses, T-bet+ Treg
cells do not typically produce IFN-g (Koch et al., 2009). However,
IFN-g-producing Treg cells have been observed during themunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc. 501
Figure 1. STAT1- and IFN-gR-Dependent Expression of T-bet by Treg Cells
(A) Flow cytometric analysis of T-bet expression by CD4+Foxp3+ Treg cells stimulated with anti-CD3/anti-CD28 in media containing IL-2 alone (shaded histo-
grams) or IL-2 + IFN-g or IL-27 (open histograms) for 5 days as indicated.
(B) Flow cytometric analysis of CXCR3 and T-bet expression by gated wild-type- or Stat1/-derived CD4+Foxp3+ splenocytes in mixed bone marrow chimeras.
Data are representative of two independent experiments with at least three mice analyzed per experiment. Graph depicts the frequency of CXCR3+T-bet+ cells
among total WT and Stat1/-derived CD4+Foxp3+ splenic Treg cells in each BM chimera examined. Linked points represent the values from individual
chimeric mice.
(C) Flow cytometric analysis of CXCR3 expression by gated wild-type- or Ifngr1/-derived CD4+Foxp3+ Treg cells in the brains of mixed bone marrow chimeras
14 days after induction of EAE.
(D) Flow cytometric analysis of CD44 and IL-10 expression byCD4+Foxp3+ Treg cells from either wild-type or Ifngr1/ donors in the brains ofmixed bonemarrow
chimeras 19 days after induction of EAE. Graphs in (C) and (D) depict the frequency of CXCR3+ or IL-10+ cells among the wild-type or Ifngr1/ Treg cells in each
chimera examined. Linked points represent the values from individual chimeric mice.
Immunity
Abortive Th1 Cell Differentiation of Treg Cellsdysregulated immune responses associated with autoimmune
disease or infection-induced immunopathologies (Oldenhove
et al., 2009; Zhao et al., 2011). This has led to the notion that
Treg cells retain a considerable degree of functional plasticity
(Zhou et al., 2009), although this notion has been questioned in
subsequent studies (Rubtsov et al., 2010; Miyao et al., 2012).
In this study, we examined the cellular and molecular pathway
leading to the upregulation of T-bet by Treg cells and explored
the mechanisms limiting their ability to acquire proinflammatory
effector functions in Th1 cell-polarizing inflammatory environ-
ments. We demonstrate that activation of STAT1 by effector
T cell-derived IFN-g induced T-bet expression in Treg cells.
However, delayed induction of the IL-12 receptor component
IL-12 Rb2 prevented Treg cells from completing STAT4-
dependent Th1 cell differentiation during acute type 1 inflamma-
tory responses. Thus, abortive Th1 cell differentiation driven by
activation of STAT1, but not STAT4, results in the generation
of functionally specialized T-bet+ Treg cells that effectively
modulate Th1 cell responses without acquiring proinflammatory
effector functions.
RESULTS
STAT1-Dependent Expression of T-bet by Treg Cells
We recently identified and characterized a population of T-bet+
CXCR3+ Treg cells that express elevated amounts of Il10 and502 Immunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc.that are important for regulating strong Th1 cell responses
(Koch et al., 2009). Moreover, the frequency of this Treg cell pop-
ulation is increased during Th1 cell responses, but substantially
reduced in mice lacking STAT1. This suggests that like effector
T cells, Treg cells upregulate T-bet during Th1 cell responses
after STAT1 activation. Consistent with this, nearly all Foxp3+
Treg cells rapidly phosphorylated STAT1 after treatment with
the STAT1-activating cytokines IFN-g or IL-27 (Figure S1 avail-
able online). Additionally, in vitro stimulation in the presence of
either IFN-g or IL-27 potently induced T-bet expression in sorted
CD4+Foxp3+CD62L+CXCR3 naive phenotype Treg cells (Fig-
ure 1A). To determine whether Treg cells are exposed to
STAT1-activating cytokines in vivo, we constructed mixed
bone marrow (BM) chimeras using congenically marked wild-
type and Stat1/ donors and compared the phenotype of
Foxp3+ Treg cells derived from each donor 8 weeks later.
Indeed, whereas 25%–30% of the splenic Treg cells from the
wild-type donor were T-bet+CXCR3+, this population of Treg
cells was nearly absent from the Stat1/ cells (Figure 1B).
Treg cell expression of T-bet and CXCR3 is reduced in mice
lacking the STAT1-activating IFN-g receptor (IFN-gR [Koch
et al., 2009]), indicating that IFN-g is the principle STAT1-acti-
vating cytokine driving the development of T-bet+CXCR3+ Treg
cells. Moreover, CXCR3+ Treg cells from Ifngr/mice displayed
a slight (<2-fold) decrease in T-bet protein expression relative to
CXCR3+ Treg cells from wild-type animals (Figure S2), further
Figure 2. T Cell-Derived IFN-g Induces
T-bet Expression by Treg Cells
(A) Representative flow cytometric analysis of
CXCR3 and T-bet expression by CD4+Foxp3+
cells isolated from the spleens of mixed bone
marrow chimeras containing T cells derived from
WT (left) or Ifng/ (right) donors. The graph shows
the frequency of CXCR3+ T-bet+ cells among total
CD4+ Foxp3+ (Treg) cells isolated from the
spleens, peripheral lymph nodes (PLN), and peri-
toneal exudate cells (PEC) of the indicated
chimeras. Each point represents an individual
mouse. Data are representative of two indepen-
dent experiments. Error bars denote SEM.
(B) Representative flow cytometric analysis of
CXCR3 and T-bet expression by gated CD4+
Foxp3+ cells isolated from the spleens of wild-type
(top panels) and Ifng/ (bottom panels) mice
immunized twice with OVAp after transfer of Th1
polarized OVA-specific CD4+ T cells (right panels)
orwithout transfer (left panels). Numbers depict the
proportion of cells positive for CXCR3 and T-bet.
Data are representative of three independent
experiments.
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Abortive Th1 Cell Differentiation of Treg Cellshighlighting the importance of IFN-gR signaling for optimal T-bet
induction in Treg cells. However, tissue inflammation results in
the upregulation of numerous inflammatory and regulatory cyto-
kines, several of which (i.e., IL-27) can activate STAT1 and may
induce T-bet and CXCR3 expression in Treg cells in the absence
of IFN-g. To determine whether these cytokines can com-
pensate for loss of IFN-g signaling during strong inflammatory
responses in vivo, we induced experimental autoimmune
encephalomyelitis (EAE), a demyelinating inflammatory disease
mediated by autoreactive Th1 and Th17 cells (Dardalhon et al.,
2008), in mixed BM chimeras containing a 1:1 ratio of congeni-
cally marked wild-type and Ifngr1/ cells. Loss of IFN-gR-
mediated signaling did not impair the accumulation of CD4+
T cells in the central nervous system (CNS; data not shown).
However, expression of T-bet and CXCR3 were substantially
reduced in Ifngr1/ Treg cells in both the CNS and spleen (Fig-
ure 1C and data not shown). Additionally, consistent with the
large amount of Il10 expressed by CXCR3+ Treg cells, Ifngr1/
Treg cells in the CNS showed decreased IL-10 production at day
19 (Figure 1D), a late time point associated with Treg cell-
mediated amelioration of disease (Korn et al., 2007; McGeachy
et al., 2005). Thus, even during strong inflammatory responses
associated with EAE, IFN-g promotes the functional specializa-
tion of Treg cells by controlling the expression of molecules
such as CXCR3 and IL-10 that are critical for Treg cell-mediated
disease suppression (McGeachy et al., 2005; Mu¨ller et al., 2007).
T Cell Derived-IFN-g Drives T-bet+ Treg Cell
Differentiation
The homeostasis of Treg cells is controlled in part by IL-2
produced by CD4+CD44hiFoxp3 effector T cells (Setoguchi
et al., 2005), establishing a link between effector T cell activation
and Treg cell abundance. To determine whether effector T cells
also control Treg cell specialization via production of IFN-g, we
injected a 9:1 ratio of BM cells from Tcrb/Tcrd/ and Ifng/
donors into irradiated Tcrb/Tcrd/ recipients in order to
construct animals in which all nonhematopoietic cells, as wellImas 90% of non-T cells, were IFN-g sufficient, whereas all
T cells were derived from Ifng/ donor BM. Control chimeras
were generated using a 9:1 mixture of Tcrb/Tcrd/ and
wild-type BM cells. We found the that frequency of T-bet+
CXCR3+ Treg cells in the spleens, peripheral lymph nodes, and
peritoneal cavities of mice lacking T cell-derived IFN-g was
substantially lower than in the wild-type control chimeras
(Figure 2A).
To determine whether IFN-g produced by effector T cells is
sufficient to induce CXCR3 and T-bet expression by Treg cells,
we transferred OVA-specific CD4+ Th1 cells from OT-II TCR
transgenic mice into wild-type and Ifng/ recipients. These
mice were then given OVA323-339 peptide (OVAp) in PBS on
days 1 and 4 after transfer, and we examined the endogenous
Treg cells in these animals 3 days later. Indeed, in both wild-
type and Ifng/ mice given OT-II Th1 cells and OVAp, we
observed a 3- to 4-fold increase in the fraction of T-bet+CXCR3+
Treg cells as compared tomice receivingOVApalone (Figure 2B).
Similarly, activation of effector CD8+ T cells fromOT-I TCR trans-
genic mice in vivo also increased Treg cell expression of T-bet
and CXCR3 (Figure S3). Thus, through the production of IFN-g,
both CD4+ and CD8+ effector T cells can directly control the
specialization of Treg cells.
IL-12R Signaling Is Dispensable for the Development
of T-bet+ Treg Cells
In addition to the STAT1 activating cytokines, IL-12 has an
essential role in Th1 cell differentiation (Trinchieri, 2003; Hsieh
et al., 1993; Manetti et al., 1993), and activation of STAT4 via
the IL-12 receptor is necessary for expression of genes required
for Th1 cell function (Thieu et al., 2008; Wei et al., 2010).
However, Treg cell expression of T-bet and CXCR3 was unal-
tered in IL-12Rb2-deficient mice (Figures 3A and S2), indicating
that STAT4 activation via IL-12R is dispensable for the differen-
tiation of T-bet+ Treg cells.
Although most T cells express the IL-12 receptor subunit
IL-12Rb1, naive CD4+ T cells lack expression of IL-12Rb2 andmunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc. 503
Figure 3. Treg Cells Do Not Express Il12rb2
or Respond to IL-12 Ex Vivo
(A) Flow cytometric analysis of CXCR3 and T-bet
expression by gated CD4+Foxp3+ splenocytes
isolated from age-matched wild-type and
Il12rb2/ mice.
(B) Representative qPCR analysis of Il12rb2 and
Il12rb1 mRNA expression by sorted Foxp3+
CXCR3+ or Foxp3CXCR3+ CD4+ splenocytes
isolated from Foxp3gfp mice.
(C) Representative flow cytometric analysis of
STAT4 phosphorylation by sorted Foxp3+CXCR3+
or Foxp3CXCR3+ CD4+ splenocytes treated for
30 min with (open histograms) or without (shaded
histograms) 25 mg/ml rmIL-12.
(D) Representative qPCR analysis of expression
the STAT4 regulated genes Nkg7, Id2, Il21, and
Ffar by sorted Foxp3+CXCR3+ or Foxp3CXCR3+
CD4+ splenocytes isolated from Foxp3gfp mice.
Data in all panels are representative of at least two
independent experiments.
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12Rb2 downstream of STAT1 and T-bet is a key checkpoint in
Th1 cell development (Afkarian et al., 2002; Mullen et al.,
2001). Indeed, whereas both Foxp3+CXCR3+ Treg cells and
Foxp3CXCR3+ Th1 cells expressed Il12rb1, expression of
Il12rb2 was 100-fold lower in CXCR3+ Treg cells (Figure 3B).
Accordingly, these cells failed to phosphorylate STAT4 in
response to IL-12 in vitro (Figure 3C). To determine whether
Foxp3+CXCR3+ Treg cells showed evidence of STAT4 activa-
tion, we compared expression of several STAT4-controlled
genes in sorted Foxp3+CXCR3+ Treg cells and Foxp3CXCR3+
Th1 cells (Wei et al., 2010). Consistent with their lack of IL-12
responsiveness, expression of each of these genes was sub-
stantially lower in the CXCR3+ Treg cells compared with the
Foxp3 Th1 cells (Figure 3D). Thus, despite having undergone
STAT1-dependent T-bet upregulation, CXCR3+ Treg cells failed
to acquire IL-12 responsiveness through upregulation of IL-
12Rb2 and consequently lacked the STAT4-dependent genetic
signature characteristic of fully differentiated Th1 cells.
Differential Regulation of IL-12Rb2 Expression
in Foxp3+ and Foxp3– Cells
The striking lack of IL-12 responsiveness in T-bet+CXCR3+ Treg
cells suggests that regulation of IL-12Rb2 expression is different
in Foxp3+ and Foxp3 cells. Alternatively, chronic TCR stimula-
tion can inhibit IL-12Rb2 induction (Schulz et al., 2009), and this
may limit its expression in autoreactive Treg cells. To differen-
tiate between these possibilities, we compared acquisition of
IL-12 responsiveness in Foxp3+ and Foxp3 CD4+ T cells stim-
ulated in vitro under identical conditions. Sorted naive pheno-504 Immunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc.type CD4+CD62L+CXCR3Foxp3 and
CD4+CD62L+CXCR3Foxp3+ T cells
were activated in the presence of IL-2
and IFN-g for 3 days, at which point the
cells were removed from the TCR stim-
ulus and cultured in cytokines for three
additional days. We measured STAT4phosphorylation after IL-12 treatment in the Foxp3+ and Foxp3
cells daily starting at day 2 of culture. IL-12 responsiveness in the
Foxp3 cells was evident by day 2 of activation, peaked by day
4, and was maintained throughout the remainder of the culture
(Figure 4A, top). In comparison, acquisition of IL-12 responsive-
ness was substantially delayed in the Foxp3+ Treg cells, which
did not become IL-12 responsive until day 4 of culture (Figure 4A,
bottom). However, by day 6 the Foxp3+ and Foxp3 cells dis-
played roughly equivalent STAT4 phosphorylation after IL-12
treatment. Importantly, Treg cells became IL-12 responsive on
day 4 of culture even when removed from the TCR stimulus at
earlier time points (day 1 or 2) postactivation (data not shown),
indicating that TCR stimulation is not the primary factor inhibiting
their expression of Il12rb2.
The delay in acquisition of IL-12 responsiveness suggests that
T-bet-dependent induction of Il12rb2 expression is impaired in
Treg cells. To directly test this, we sorted Foxp3+ and Foxp3
CD4+T cells from T-bet-deficient Tbx21/Foxp3gfpmice, stimu-
lated them in vitro with plate-bound anti-CD3 and anti-CD28,
and infected them with a retroviral construct encoding a T-bet-
estrogen receptor (T-bet-ER) fusion protein whose activity is
modulated by the estrogen analog 4-hydroxytamoxifin (4-HT).
The infected cells were cultured for 3 days with varying concen-
trations of 4-HT, at which point we assessed their expression of
Cxcr3 and Il12rb2. As expected, activation of T-bet led to robust
induction ofCxcr3mRNA expression in both Foxp3+ and Foxp3
cells (Figure S4). However, induction of Il12rb2 was observed
only in Foxp3 cells (Figure 4B), demonstrating that the regula-
tion of this gene is markedly different in Foxp3+ and Foxp3
CD4+ T cells.
Figure 4. Differential Regulation of Il12rb2 in
Foxp3+ and Foxp3– T Cells
(A) Flow cytometric analysis of STAT4 phosphor-
ylation by CD4+Foxp3 (top) or CD4+Foxp3+
(bottom) cells isolated at the indicated time points
after activation in the presence of IFN-g and
treated for 30 min with (open histograms) or
without (shaded histograms) 25 mg/ml rmIL-12.
Data are representative of three independent
experiments.
(B) qPCR analysis of Il12rb2 mRNA expression by
CD4+Foxp3+ and CD4+Foxp3 cells isolated from
Tbx21/Foxp3gfp mice, infected with the T-bet-
ER encoding retroviruses, and cultured for 3 days
with the indicated doses of 4-HT. Data are pre-
sented as fold induction of mRNA expression over
infected cells not given 4-HT and are representa-
tive of two independent experiments.
(C) Distribution of H3K4me3 and H3K27me3 his-
tone modifications along the Il12rb2 locus in the
indicated CD4+ T cell subsets. ChIP-Seq data (Wei
et al., 2009) was mapped to the Feb. 2006
(NCBI36/mm8) mouse genome assembly with
the UCSC genome browser. Annotation of the
Il12rb2 locus appears above, and the peaks
represent the density of sequence tags assigned
to each chromosomal region. The region sur-
rounding the proximal promoter and exon 1 of
Il12rb2 is boxed.
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Il12rb2 in Foxp3+ and Foxp3 cells, we compared the epigenetic
status of the Il12rb2 promoter in naiveCD4+ T cells and Treg cells
through analysis of genome-wide histone modification data
(Wei et al., 2009). In naive CD4+ T cells, the Il12rb2 promoter
is marked by both permissive H3K4me3 and repressive
H3K27me3 histone modifications (Figure 4C, top). Consistent
with the rapid induction of Il12rb2 in developing Th1 cells, this
bivalent state is believed to repress gene transcription while
keeping the promoter ‘‘poised’’ for activation-induced expres-
sion (Bernstein et al., 2006). By contrast, only H3K27me3 marks
are found at the Il12rb2 promoter in Treg cells (Figure 4C,
bottom). Thus, expression in Treg cells probably requires sub-
stantial epigenetic remodeling of the Il12rb2 promoter, involving
both the removal of repressive histone modifications and the
addition of permissive modifications.
IL-12 Can Functionally Reprogram Treg Cells
Although IL-12 has been reported to induce IFN-g-production
by Foxp3+ Treg cells in vitro, it does so inefficiently, with only
5% of CD4+Foxp3+ cells producing IFN-g after activation for
3 days in the presence of IL-12 (Wei et al., 2009). Moreover,
a recent study demonstrating that Foxp3+ cells contain a small
population of effector T cells suggests that at least some of the
observed IFN-g production could result from these con-
taminating cells (Miyao et al., 2012). Indeed, we found that IL-
12 alone failed to induce IFN-g expression by sorted CD4+
CD62L+CXCR3Foxp3+ naive phenotype Treg cells, which are
less likely to contain contaminating activated effector cells
(Figure S5).ImThe stringent regulation of IL-12Rb2 expression in autoreac-
tive Treg cellsmay serve as a tolerancemechanism that prevents
them from undergoing IL-12-dependent functional differentia-
tion and acquiring potentially dangerous proinflammatory prop-
erties such as the ability to produce IFN-g. Alternatively, the
inability of Treg cells to produce IFN-g may result from direct
inhibition of Ifng expression by Foxp3 or other Treg cell-specific
repressive mechanisms. To determine how IL-12 receptor
signaling functionally impacts Treg cells, we activated sorted
CD4+Foxp3+CD62L+CXCR3 naive phenotype Treg cells in the
presence of IFN-g for 6 days to render the cells IL-12 responsive.
We then cultured these cells with or without IL-12 for 3 additional
days, examined their ability to produce IFN-g, and assessed
their suppressive function in vitro. Despite the reported ability
of Foxp3 to directly inhibit IFN-g expression (Ono et al., 2007),
IL-12 potently induced IFN-g production in both Foxp3+ and
Foxp3 cells that had been ‘‘primed’’ with IFN-g (Figure 5A). In
addition, IL-12 treatment substantially reduced the ability of
Treg cells to inhibit effector T cell proliferation (Figure 5B).
Thus, IL-12 can alter the balance between pro- and anti-inflam-
matory functions in Treg cells, emphasizing the importance of
regulating IL-12 responsiveness in order to maintain Treg cell-
mediated immune suppression during strong type 1 inflamma-
tory responses.
Treg Cells Undergo Abortive Th1 Cell Development
during Acute Bacterial Infection
Although robust, production of IL-12 during infection with intra-
cellular pathogens is typically very transient. Because Treg cells
are poised to respond to IFN-g, but display delayed induction ofmunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc. 505
Figure 5. IL-12 Can Functionally Reprogram
Treg Cells
(A) Flow cytometric analysis of CD4 and IFN-g
expression by gated CD4+Foxp3+ (left) or Foxp3
(right) cells after stimulation with PMA and ion-
omycin. Prior to analysis, sorted Foxp3+ and
Foxp3 naive phenotype cells were activated
and cultured for 6 days in the presence of IL-2 and
IFN-g, after which they were washed and incu-
bated for 3 days in media containing IL-2 with or
without IL-12, as indicated.
(B) Flow cytometric analysis of CFSE dilution
by labeled CD4+CD25 effector T cells activated
in the presence of the indicated cellular ratios
of CD4+Foxp3+ Treg cells sorted from Foxp3gfp mice activated in the presence of IFN-g and/or IL-12 as described in (A). Proliferation of effector T cells in the
absence of Treg cells is displayed in the dashed histrogram overlay in the upper-left panel. Data are representative of three independent experiments.
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responses they would undergo partial Th1 cell differentiation
driven by activation of STAT1 but not STAT4. To test this, we
monitored cytokine responses in different splenic lymphocyte
populations throughout the course of acute infection with
the intracellular bacterial pathogen L. monocytogenes, which
provokes a strong, IL-12-dependent Th1 response.
Consistent with the transient appearance of IL-12p70 in the
serum of L. monocytogenes-infected mice (Way et al., 2007;
Seki et al., 2002), the Il12a and Il12b genes were strongly upre-
gulated in the spleen within 1 day of infection, after which their
expression was rapidly extinguished (Figure 6A and data not
shown). Moreover, direct ex vivo analysis of CD4+Foxp3CD44hi
T cells (without any in vitro restimulation) showed that 25% of
these effector T cells in the spleen were phospho(p)-STAT4+
on day 1 after infection and that a substantial fraction of the
pSTAT4+ cells were also producing IFN-g (Figures 6B and 6C).
However, mirroring the sharp decline in IL-12 cytokine expres-
sion, the frequency of pSTAT4+ IFN-g-producing effector
T cells fell dramatically on days 2 and 3 after infection. By
contrast, less than 5% of splenic Treg cells were pSTAT4+
directly ex vivo at any time point examined during infection
(Figures 6B, middle, and 6C). Indeed, IL-12 responsiveness, as
measured by the ability to phosphorylate STAT4 after in vitro
IL-12 treatment, emerged in only a small fraction of Treg cells
between days 3–5 postinfection, after production of IL-12 had
ceased (Figure 6B, right).
Coincident with the robust IFN-g production by effector
T cells, we observed a dramatic increase in STAT1 phosphoryla-
tion in Treg cells on days 1 and 2 postinfection (Figure 7A).
Accordingly, expression of T-bet and CXCR3 was dramatically
elevated in Treg cells from L. monocytogenes infected mice.
However, consistent with their inability to respond to IL-12 early
in infection, very few Treg cells acquired the ability to produce
IFN-g (Figure 7B). To determine whether IL-12 receptor signaling
is required for the small degree of IFN-g production by Treg cells
during L. monocytogenes infection, we reconstituted Tcrb/
Tcrd/ mice with a 1:1 mixture of splenocytes from wild-
type and Il12rb2/ donors and infected them with
L. monocytogenes 10 days later. Indeed, whereas a small frac-
tion of wild-type Treg cells acquired the ability to produce
IFN-g after infection, this was blunted in the Il12rb2/ Treg cells
(Figure 7C). Taken together, these data confirm our in vitro find-
ings regarding the ability of Treg cells to respond to IFN-g and506 Immunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc.IL-12 in an in vivo setting of acute inflammation and indicate
that the relative inability of Treg cells to respond to IL-12 limits
their functional reprogramming into IFN-g-producing cells.
DISCUSSION
In this study, we examined how Treg cells respond to inflamma-
tory cytokines produced during strong Th1 cell responses in vitro
and in vivo. We define a mechanism whereby impaired upregu-
lation of IL-12Rb2 causes Treg cells to undergo abortive
Th1 cell differentiation driven by activation of STAT1 but not
STAT4. This results in the phenotypic and functional specializa-
tion of Treg cells via induction of T-bet and prevents them
from IL-12-dependent functional reprogramming leading to
their acquisition of potentially harmful proinflammatory effector
functions.
Increasing evidence indicates that Treg cells both sense and
respond to changes in the immune environment and that this
is necessary for proper immunoregulation. For instance, IL-10-
dependent activation of STAT3 is important for the ability of
Treg cells to effectively restrain Th17 cell-mediated inflammatory
responses (Chaudhry et al., 2011). Additionally, Treg cell abun-
dance is tightly linked to the size of the dendritic cell compart-
ment, given that depletion or expansion of dendritic cells in vivo
serves to reduce or augment Treg cell numbers, respectively
(Darrasse-Je`ze et al., 2009). Treg cells are also sensitive to
changes in the amount of IL-2 produced by CD4+Foxp3CD44hi
T cells, and this is thought to be a mechanism by which Treg cell
abundance can be rapidly altered as the number of effector
T cells fluctuates (Setoguchi et al., 2005). Here, we show that
Treg cells upregulated expression of the key transcription factor
T-bet downstream of STAT1 activation in direct response to
IFN-g produced by CD4+ and CD8+ effector T cells. Thus, in
addition to controlling Treg cell abundance, cytokines produced
by effector T cells can also drive the phenotypic and functional
specialization of Treg cells. However, although we demon-
strated that T cells are a key source of the IFN-g that acted on
Treg cells in vivo, other IFN-g-producing populations, such as
NK and NKT cells, may also influence the phenotypic and func-
tional specialization of Treg cells when they are potently acti-
vated. Additionally, other STAT1-activating cytokines such as
IL-27 or type 1 interferons may also help drive T-bet expression
by Treg cells when produced in abundance during parasitic or
viral infections.
Figure 6. Treg Cells Do Not Phosphorylate
STAT4 during Acute L. monocytogenes
Infection
(A) qPCR analysis of Il12a expression in total
spleen of mice at the indicated times during acute
L. monocytogenes infection. The mean and SEM
of measurements from three different animals at
each time point are presented.
(B) Representative flow cytometric analysis of
pSTAT4 and IFN-g expression by gated effector
(top) and regulatory (bottom) splenic CD4+ T cells
at the indicated times during L. monocytogenes
infection. Analyses were performed directly
ex vivo (without any in vitro restimulation) by
isolating cells directly into Fix and Perm buffer.
(C) Graphs depicting the percentage of pSTAT4+
cells among gated CD4+Foxp3CD44hi effector
T cells (left) or CD4+Foxp3+ Treg cells (middle and
right) from the spleens of individual mice analyzed
either directly ex vivo (left and middle) or after IL-
12 stimulation in vitro (right) at the indicated times
during acute L. monocytogenes infection. Error
bars in all panels denote SEM.
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IL-12-dependent STAT4 activation is required for full Th1 cell
differentiation. Indeed, STAT4 and T-bet have distinct, yet over-
lapping functions in establishing the Th1 cell-specific gene
expression program. For instance, STAT4 induces the high level
of T-bet expression necessary for the terminal differentiation of
Th1 effector cells, and activated STAT4 synergizes with T-bet
to drive expression of IFN-g (Thieu et al., 2008; Mullen et al.,
2001). Similarly, IL-12 controls the level of T-bet expression in
CD8+ effector T cells and dictates whether CD8+ T cells become
‘‘short-lived effector cells’’ or long-lived ‘‘memory-precursor
effector cells’’ (Joshi et al., 2007). Consistent with their lack of
ex vivo IL-12 responsiveness, T-bet+CXCR3+ Treg cells express
5- to 10-fold less T-bet than fully differentiated Th1 cells and do
not produce IFN-g (Koch et al., 2009). Moreover, we show that
they lack expression of other STAT4 regulated genes, and thus
we conclude that these Treg cells have undergone a form
of incomplete Th1 cell differentiation driven by activation of
STAT1 but not STAT4.
Despite being a key checkpoint in Th1 cell development, the
molecular control of Il12Rb2 expression is still poorly under-
stood. Although its expression after STAT1 activation is T-bet
dependent, it is unclear whether T-bet acts directly on the
Il12rb2 locus. Notably, a number of IFN-g activation site (GAS)
elements are found upstream of the Il12rb2 coding sequence,
indicating that expression of this gene may be directly regulated
by STAT1 (Letimier et al., 2007). Moreover, IL-12-dependent
STAT4 activation can feed-forward and enhance Il12rb2 expres-
sion (Becskei and Grusby, 2007). In addition, TCR stimulation
alone results in recruitment of the Brg1-containing BAF chro-
matin remodeling complex to the Il12rb2 locus, which promotes
histone hyperacetylation and potentiates STAT-induced Il12rb2
expression (Letimier et al., 2007). However, the presence of
abundant H3K27me3 histone modifications at the Il12rb2
promoter probably acts to temporally delay IL-12Rb2 induction
in Treg cells until H3K27 demethylases such as Jumonji 3 canImbe recruited and remove this chromatin mark (De Santa et al.,
2007). Although Foxp3 is a potent transcriptional repressor, it
is not found at or near the Il12rb2 locus (Zheng et al., 2007;
Marson et al., 2007), and deletion of Foxp3 in established
Treg cells does not result in Il12rb2 upregulation (Williams and
Rudensky, 2007). In addition, IL-12 can potently induce IFN-g
production from TGF-b-induced Treg cells in vitro (Feng et al.,
2011), which are believed to retain a greater degree of pheno-
typic and functional plasticity than the in vivo-derived natural
Treg cells we examined. Thus, repression of Il12rb2 expression
appears to be part of the Foxp3-independent program of Treg
cell differentiation, and further studies are needed to establish
the precise molecular mechanisms that regulate Il12rb2 expres-
sion in effector and regulatory T cells.
During acute inflammation, cells of the innate immune
system transiently produce IL-12 after pathogen recognition,
and we showed that delayed induction of IL-12Rb2 prevented
Treg cells from sensing and responding to IL-12 during acute
L. monocytogenes infection. However, acquisition of IL-12
responsiveness after prolonged STAT1 activation predicts that
Treg cells would be more susceptible to functional reprogram-
ming during sustained or dysregulated inflammatory responses.
Accordingly, we observed that IL-12 potentiated production of
IFN-g and decreased the suppressive function of IFN-g pre-
treated Treg cells. Moreover, unlike the transient IL-12 produc-
tion we observed during L. monocytogenes infection, sustained
IL-12 production during the lethal intestinal inflammation caused
by oral infection with Toxoplasma is associated with functional
reprogramming of Treg cells into IFN-g-producing Th1-like cells
(Oldenhove et al., 2009), and IFN-g-producing Treg cells are also
found in the CNS during chronic corona-virus-induced enceph-
alomyelitis (Zhao et al., 2011). Finally, consistent with our results
indicating that sustained STAT1 activation renders Treg cells
susceptible to IL-12-mediated functional reprogramming,
IFN-g production is observed in Treg cells displaying elevated
STAT1 activation due to loss of the microRNA miR-146amunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc. 507
Figure 7. Treg Cells Undergo Abortive
Th1 Differentiation during Acute
L. monocytogenes Infection
(A) A graph depicting the mean fluorescence
intensity of pSTAT1 in gated CD4+Foxp3+ Treg
cells from the spleens of individual mice analyzed
directly ex vivo at the indicated times during acute
L. monocytogenes infection.
(B) Representative flow cytometric analysis of
T-bet and CXCR3 (left) or CD44 and IFN-g (right)
expression by gated CD4+Foxp3+ splenic Treg
cells from either uninfected mice or at day 7 after
L. monocytogenes infection.
(C) Representative flow cytometric analysis (left) of
CD44and IFN-gexpressionbygatedwild-typeand
Il12rb2/ Treg cells from TCRb/ TCRd/ mice
reconstituted with a 1:1 mixture of wild-type and
Il12rb2/ splenocytes 10 days prior to infection
with L. monocytogenes. The graph (right) depicts
the frequency of IFN-g+ cells among total WT and
Il12rb2/-derived CD4 +Foxp3 + splenic Treg cells
in each animal examined. Error bars in all panels
denote SEM.
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inhibit expression of IFN-g by Treg cells (Ono et al., 2007), IL-
12 appears to be sufficient to overcome this blockade, and
impaired IL-12Rb2 induction helps limit the functional reprog-
ramming of Treg cells during Th1 cell inflammation. This also
provides a molecular mechanism that helps reconcile conflicting
data regarding the susceptibility of Treg cells to functional
reprogramming in resolving versus chronic inflammatory condi-
tions (Oldenhove et al., 2009; Rubtsov et al., 2010; Zhao et al.,
2011).
By demonstrating that cytokines produced by activated
effector T cells can influence the specialization of Treg cells, our
data help elucidate how immune homeostasis is maintained after
the initiation of robust T cell responses.We also identify the regu-
latedexpressionof IL-12Rb2asakeycheckpoint that functions to
prevent Treg cells from obtaining proinflammatory effector func-
tions and thatmay contribute to the ‘‘functional plasticity’’ of Treg
cells observed during uncontrolled inflammation. Further exam-
ining how Treg cells respond to specific signals in the immune
environment will provide new insights into how Treg cell activity
is controlled during different types of immune responses, and is
vital for developing and optimizing cellular and molecular thera-
pies aimed at manipulating Treg cell activity in the contexts of
autoimmunity, cancer, transplantation, and chronic infection.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J, B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J (Tcrb/Tcrd/), B6.129S7-
Ifngr1tm1Agt/J (Ifngr1/), B6.129S7-Ifngtm1Ts/J (Ifng/), B6.129S1-
Il12rb2tm1Jm/J (Il12rb2/), B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II), and B6-
Tg(TcraTcrb)1100Mjb/J (OT-I) mice were purchased from the Jackson508 Immunity 37, 501–510, September 21, 2012 ª2012 Elsevier Inc.Laboratory. B6.SJL-Ptprca/BoyAiTac (CD45.1)
mice were purchased from Taconic Farms.
Foxp3gfp mice were provided by A. Rudensky
(Memorial Sloan-Kettering Cancer Center).
Tissues from Stat1/ mice were provided by M.
Krishna-Kaja (University of Washington). Allanimals were housed and bred at the Benaroya Research Institute Seattle,
WA and experiments were performed in accordance within the guidelines of
the Animal Care and Use Committees of the Benaroya Research Institute.
Cell Isolations
Lymphocytes were isolated from the spleens and lymph nodes (LNs) by tissue
disruption with glass slides followed by filtration through a 100 mM filter. CNS
lymphocytes were recovered from perfused animals by grinding brain and
spinal cord tissue through a 100 mm filter with the plunger of a 5 mL syringe.
Cells were pelleted by centrifugation at 3200 rpm for 15 min and resuspended
in 6 mL of 37% Percoll (GE Healthcare). Cells were centrifuged again at
3200 rpm for 15 min (brake off) and lymphocytes were recovered after evacu-
ation of the fatty supernatant.
Bone Marrow Chimeras
BM cells were depleted of CD4+ cells with anti-CD4 microbeads (Miltenyi
Biotech) and injected retro-orbitally into lethally irradiated (1000 Rad) Tcrb/
Tcrd/ mice. Chimeras received 6 to 10 3 106 cells of a 1:1 mixture of wild-
type (CD45.1+) and knockout (CD45.2+) BM, or 9 3 106 TCRbd-KO BM cells
mixed with 1 3 106 wild-type or Ifng/ BM cells as indicated.
Flow Cytometry and Cell Sorting
Data were acquired on LSRII flow cytometers (BD Biosciences) and analyzed
with FlowJo software (Treestar). For cell sorting experiments, CD4+ cells were
enriched with Dynal CD4 T cell negative isolation kit (Invitrogen), stained for
desired cell surface markers, and isolated with a FACS Vantage or FACS
Aria (BD Biosciences). For intracellular staining of IFN-g, Foxp3, and/or
T-bet, lymphocytes were surface stained, then permeabilized with the
eBioscience FixPerm buffer. For intracellular cytokine staining after restimula-
tion, cells were stimulated with 50 ng/mL phorbol 12-myristate 13-acetate
(PMA) and 1 mg/mL ionomycin in the presence of 10 mg/mL monensin for
4 hr at 37C, 5%CO2 prior to staining.
Phospho-STAT Staining
Cells were stimulated for 30 min in the presence or absence of 25 ng/mL
recombinant mouse (rm)IL-12 (eBioscience), IFN-g (Biolegend) or IL-27
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Abortive Th1 Cell Differentiation of Treg Cells(eBioscience). Cells were then and fixed for 20 min in BD Fix and Perm buffer
at room temperature (BD Biosciences), washed with BD Perm Wash buffer,
and fixed in 90% ice-cold methanol for 30min on ice. Cells were washed
two times with BD Perm/Wash and stained with antibodies against cell surface
and intracellular markers, including pSTAT4 (Y693; BD Biosciences) and
pSTAT1 (Y701; BD Biosciences), in BD PermWash for 45min at room temper-
ature. For direct ex vivo pSTAT and cytokine staining,1/5 of each spleen was
ground between glass slides in BD Fix and Perm buffer, left for 20 min at room
temperature, washed, fixed in 90% methanol, and stained as described
above.
In Vitro T Cell Culture
CD4+CD62L+CXCR3 Foxp3+ and Foxp3 cells were FACS sorted from
Foxp3gfpmice. A total of 1.5 to 23 106 cells were stimulated with plate-bound
anti-CD3 (2C11; UCSF hybridoma core) and anti-CD28 (37.51; UCSF
hybridoma core) in medium containing 500 units/mL rmIL-2. rmIFN-g, rmIL-
27, and rmIL-12p70 were added to some cultures at 25 ng/mL as indicated.
All cytokines used were from eBioscience or Biolegend. Cells were cultured
for 72 hr at 37C, at which point they were analyzed or removed from the
CD3 and CD28 stimulus and cultured in fresh medium containing cytokines
for 48–72 more hours at 37C. In some assays, after 144 hr of culture, cells
were washed and cultured for an additional 3 days with 500 units/mL IL-2 in
the presence or absence of 25 ng/mL IL-12.
Adoptive Transfer and OVA Peptide Administration
A total of 5 3 106 polarized OT-II+CD4+ or OT-I+CD8+ cells were adoptively
transferred into wild-type or Ifng/ mice via retro-orbital injection on day 0
and recipients were injected intraperitoneally with 200 mg OVA peptide323-339
(for OT-II adoptive transfers) or OVA peptide257-264 (for OT-I adoptive transfers)
in PBS on days 1 and 4. All mice were sacrificed for analysis on day 7.
In Vitro Suppression Assays
A total of 7.5 3 105 CFSE-labeled CD4+CD25 T cells were incubated with
7.5 3 105 irradiated (2,500 Rad) Tcrb/Tcrd/ splenocytes (CD45.2+),
with or without addition of Treg cells at the indicated ratios, and stimulated
with 0.15 mg/ml soluble anti-CD3 (2C11) for 72 hr.
L. Monocytogenes Infection
The recombinant LM-OVA strain was provided by M. Bevan (University of
Washington). A total of 104 cfu LM-OVA were injected intravenously into
mice after growth to log phase (OD600 = 0.1–0.4) in brain heart infusion media
(BD Biosciences) at 37C.
Induction of EAE
Mice were immunized subcutaneously (s.c.) in the flank with 200 mg myelin
oligodendrocyte glycoprotein (MOG) 35–55 peptide in CFA. A total of 200 ng
of pertussis toxin in PBS was injected intravenously on day 0 and day 2 after
immunization.
Retroviral Transduction Assays
FACS-purified CD4+Foxp3+ and CD4+Foxp3 cells from Tbx21/ Foxp3gfp
mice were plated in a 24-well flat-bottom plate precoated with 1 mg/ml anti-
CD3 (2C11) and 1 mg/ml anti-CD28 (37.51) in medium with 500 units/ml
rmIL-2. After 72 hr, cells were resuspended in retroviral supernatant containing
8 mg/ml polybrene (Sigma-Aldrich) and were centrifuged at 2500 rpm for 2 hr at
37C, then cultured at 37C in complete RPMI containing 500 U/ml rmIL-2 and
4-hydroxytamoxifen (Sigma-Aldrich). Infected cells were isolated 72 hr later
with anti-human CD2 microbeads (Miltenyi Biotech) and expression of Cxcr3
and Il12rb2 was assessed by quantitative PCR.
Quantitative PCR
RNA extraction was performed with QIAGEN RNeasy columns (QIAGEN)
and cDNA was generated with an Omniscript RT Kit (QIAGEN) according
to the manufacturer’s instructions. Presynthesized Taqman Gene Expres-
sion Assays (Applied Biosystems) were used for amplifying Il12Rb2
(Mm00434200_m1) or Cxcr3 (Mm99999054_s1) mRNA transcripts in analysis
of T-bet-ER transduced cells. Target gene values are expressed relative to
Actb, which was analyzed with the sense primer 50-TGACAGGATGCAGAAGGImAGAT-30, anti-sense primer 50-GCGCTCAGGAGGAGCAAT-30, and probe
50-FAM-ACTGCTCTGGCTCCTAGCACCAT-TAMRA-30. In all other assays,
expression of Il12rb1, Il12rb2, Il12a, Nkg7, Il21, Id2, and Ffar were assessed
with Maxima SYBRGreen/ROX qPCRMaster Mix (Fermentas) and normalized
to expression of Gapdh.
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